Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-02-03

Clinical Trial Update: Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern [Phase 2]

View source ↗

Summary

Phase 2 trial update for Staccato alprazolam in epilepsy with predictable seizures has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Staccato Alprazolam (Alprazolam)

Snippet

Sponsor: Engage Therapeutics, Inc. | Conditions: Epilepsy | Phase 2 | Status: COMPLETED | Results posted: 2021-02-03